Resmed Inc Drc Stock Fundamentals
| RMD Stock | 38.59 0.48 1.26% |
Resmed Inc DRC fundamentals help investors to digest information that contributes to Resmed's financial success or failures. It also enables traders to predict the movement of Resmed Stock. The fundamental analysis module provides a way to measure Resmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Resmed stock.
At this time, Resmed's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 1.3 B in 2024, whereas Net Income From Continuing Ops is likely to drop slightly above 590.7 M in 2024. Resmed | Select Account or Indicator |
Resmed Inc DRC Company Return On Equity Analysis
Resmed's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Resmed Return On Equity | 0.24 |
Most of Resmed's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Resmed Inc DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Resmed Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Resmed Inc DRC has a Return On Equity of 0.2357. This is 100.98% lower than that of the Health Care Equipment & Supplies sector and 103.94% lower than that of the Health Care industry. The return on equity for all Australia stocks is 176.03% lower than that of the firm.
Resmed Inc DRC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Resmed's current stock value. Our valuation model uses many indicators to compare Resmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Resmed competition to find correlations between indicators driving Resmed's intrinsic value. More Info.Resmed Inc DRC is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Resmed Inc DRC is roughly 1.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Resmed's earnings, one of the primary drivers of an investment's value.Resmed Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Resmed's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Resmed could also be used in its relative valuation, which is a method of valuing Resmed by comparing valuation metrics of similar companies.Resmed is currently under evaluation in return on equity category among its peers.
Resmed Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 57.19 B | ||||
| Shares Outstanding | 1.47 B | ||||
| Shares Owned By Institutions | 10.51 % | ||||
| Price To Book | 7.06 X | ||||
| Price To Sales | 11.73 X | ||||
| Revenue | 4.69 B | ||||
| Gross Profit | 2.39 B | ||||
| EBITDA | 1.53 B | ||||
| Net Income | 1.02 B | ||||
| Cash And Equivalents | 273.71 M | ||||
| Total Debt | 873.93 M | ||||
| Book Value Per Share | 35.39 X | ||||
| Cash Flow From Operations | 1.4 B | ||||
| Earnings Per Share | 1.17 X | ||||
| Price To Earnings To Growth | 1.90 X | ||||
| Target Price | 25.95 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 56.37 B | ||||
| Total Asset | 6.87 B | ||||
| Retained Earnings | 4.99 B | ||||
| Working Capital | 1.45 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 6.87 B | ||||
| Last Dividend Paid | 1.97 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 152.6 M | 160.2 M | |
| Total Revenue | 4.7 B | 4.9 B | |
| Cost Of Revenue | 2 B | 2.1 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Resmed Stock Analysis
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.